title: Impaired leukocyte phagocytosis in patients undergoing hemihepatectomy for liver metastases.
abstract: Patients undergoing partial hepatectomy have an increased susceptibility to infection. To investigate whether this increased risk is related to impaired leukocyte function, we studied polymorphonuclear leukocyte (PMN) phagocytosis in patients undergoing a hemihepatectomy because of liver metastasis (LM, n = 11) and in patients undergoing major abdominal surgery because of abdominal malignancy (AM, n = 8). Eight healthy volunteers (HVs) served as controls. Leukocyte suspensions were incubated with fluorescein isothiocyanate-labeled Staphylococcus aureus, and phagocytosis was measured by flow cytometry. Preoperative PMN phagocytosis, in the presence of autologous plasma, was significantly less in patients with LM compared with patients with AM or HVs. This impaired phagocytosis was potentially restored in the presence of normal plasma. The decreased phagocytic capacity of PMNs from patients with LM was not related to levels of known plasma opsonins or phenotypic changes of PMNs. Rather, it was related to a deficiency of unidentified plasma factors. After surgery, the phagocytic capacity of PMNs of patients with AM decreased by approximately 30%, which correlated with decreasing levels of immunoglobulin G and C3. In conclusion, patients with LM had a decreased PMN phagocytic capacity before surgery. This impairment in phagocytosis disappeared 1 week after surgery. We propose that the presence of LM leads to a deficiency of factor(s) in the blood that impairs PMN phagocytic capacity.
authors.affiliation: Department of Surgery, Free University Hospital, Amsterdam, The Netherlands.
authors.forename: M J
authors.initials: MJ
authors.lastname: Wiezer
authors.forename: C
authors.initials: C
authors.lastname: Meijer
authors.forename: H P
authors.initials: HP
authors.lastname: Wallast-Groenewoud
authors.forename: A T
authors.initials: AT
authors.lastname: Tool
authors.forename: H A
authors.initials: HA
authors.lastname: Prins
authors.forename: A P
authors.initials: AP
authors.lastname: Houdijk
authors.forename: R H
authors.initials: RH
authors.lastname: Beelen
authors.forename: S
authors.initials: S
authors.lastname: Meijer
authors.forename: C E
authors.initials: CE
authors.lastname: Hack
authors.forename: P A
authors.initials: PA
authors.lastname: van Leeuwen
mesh_terms: D016022:Case-Control Studies; D015179:Colorectal Neoplasms / Q000473:pathology; D003176:Complement C3 / Q000276:immunology; D005260:Female; D005434:Flow Cytometry; D006498:Hepatectomy; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D008113:Liver Neoplasms / Q000276:immunology / Q000556:secondary* / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009504:Neutrophils / Q000276:immunology*; D010587:Phagocytosis; D013211:Staphylococcus aureus / Q000276:immunology
chemical_list: D003176:Complement C3; D007074:Immunoglobulin G